Bonesupport Holding AB
STO:BONEX
Bonesupport Holding AB
STO:BONEX
Price:
184
SEK
3.9%
Market Cap:
kr12.1B
Relative Value
The Relative Value of one
BONEX
stock under the Base Case scenario is
287.29
SEK.
Compared to the current market price of 184 SEK,
Bonesupport Holding AB
is
Undervalued by 36%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BONEX
Relative Value
Base Case
287.29
SEK
Undervaluation 36%
Multiples Across Competitors
BONEX Competitors Multiples
Bonesupport Holding AB Competitors
Bonesupport Holding AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Bonesupport Holding AB
STO:BONEX
|
12.4B SEK | 11 | 81.2 | 53.9 | 55.6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
395.8B USD | 6.6 | 168.6 | 16.3 | 23.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202.7B USD | 5.5 | 26.3 | 15 | 15 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
188B USD | 6.4 | 22.1 | 15 | 15 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
119B USD | 9.9 | 30.1 | 23 | 24 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD | 5.8 | 18.3 | 13.9 | 15.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
74.1B AUD | 3.3 | 17.2 | 11.8 | 14.7 | |
| NL |
|
argenx SE
XBRU:ARGX
|
44.2B EUR | 14.6 | 34.2 | 58.9 | 60.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
